Levels of DDIT3 and MAP1LC3B-II did not increase in ATF4-knockdown U251 cells, despite treatment with FKB, to the levels in control-knockdown cells (Physique 5B)
Levels of DDIT3 and MAP1LC3B-II did not increase in ATF4-knockdown U251 cells, despite treatment with FKB, to the levels in control-knockdown cells (Physique 5B). pseudokinase 3) increased. In addition, based on the phosphorylation status, the AKT-MTOR-RPS6KB1 pathway was inhibited, which induced autophagy in GBM cells. Inhibition of autophagy by autophagy inhibitors 3-methyladenine SPP1 and chloroquine or knockdown of or caused FKB-treated U251 cells to switch from senescence to apoptosis. Finally, knockdown of ATG5 or treatment with chloroquine in combination with FKB, significantly inhibited tumor growth and ~?15%, untreated treated cells). These results indicated that FKB potently arrested proliferation in GBM cells and in a dose-dependent manner (Physique 1B and 1C). FKB induces cellular senescence in GBM cells in vitro Chemotherapeutic brokers lead to decreases in cancer cell proliferation through a variety of biological processes, including apoptosis and cellular senescence. GBM cells have been shown to undergo apoptosis or cellular senescence in response to ionizing radiation, for example, which is usually mediated by the PTEN tumor suppressor protein [20]. In the case of FKB, studies have shown that this molecule induces apoptosis in a variety of malignancy cell types [15,16,21]. We therefore investigated first whether FKB induced apoptosis in GBM cells. Increases in the percentage of apoptotic cells after FKB treatment were not statistically significant in wild-type cell lines, LN18 and LN229 (Physique S1). These results indicated that this inhibitory effect of FKB observed in these cell lines was not through induction of apoptosis. Alternatively, we examined whether FKB brought on senescence in GBM cells. Three different assays were used. First, distribution of the cell cycle as determined by flow cytometry revealed that GBM cells were primarily arrested at the G2/M phase after FKB treatment in all 3 cell lines (~?12% ~?35%, untreated treated cells; Physique 2A). Second, FKB treatment led to an increase in nuclei positive for phosphorylated (Ser139) H2AFX (commonly termed H2AFX) which detects a cause of senescence, DNA double-strand breaks (Physique 2B and 2C and Physique S2). Finally, accumulation of senescent SA-GLB1 positive cells in response to FKB was statistically significant in all cell lines (increases of ~?10% to 20% relative to untreated cells; Physique 2D, 2E and S3). These results indicated HG6-64-1 that FKB induced cellular senescence in GBM cell lines (#1 and #2) or (D) (#1 and #2). After 48?h, cells were treated with FKB (3 g/mL) HG6-64-1 or DMSO and then HG6-64-1 harvested after another 48?h. Data are representative of 3 impartial experiments. (E) Fluorescence images of GFP-MAP1LC3B puncta in U251 cells pretreated with autophagy inhibitors (3-MA or CQ) or transfected with siRNAs followed by exposure to FKB (3 g/mL) or DMSO for another 48?h (scale bars: 50 m). (F) Graphical representation of the quantification of GFP-MAP1LC3B puncta. All data are expressed as the mean ?SD of values from experiments performed in triplicate. * or siRNAs to inhibit protein expression of ATG5 or ATG7 in the presence of FKB. Western blot analysis and fluorescence microscopy exhibited that knockdown of ATG5 or ATG7 led to decreased MAP1LC3B-II formation (Physique 4C and 4D) and number of MAP1LC3B puncta, respectively (Physique 4E and 4F). Taken HG6-64-1 together, these data indicated that FKB induced autophagy in U251, U87, and T98 cell lines siRNAs for 48?h followed by exposure to FKB (3 g/mL) or DMSO for another 48?h; (C) DDIT3, MAP1LC3B, and GAPDH in U251 cells transfected with control or siRNAs for 48?h followed by exposure to FKB (3 g/mL) or DMSO for another 48?h; and (D) ATF4, DDIT3, MAP1LC3B, and GAPDH in U251 cells pretreated with 4-PBA (1?mM) for 30?min followed by exposure to FKB (3 g/mL) or DMSO for another 48?h. Numbers below the blots correspond to relative quantification by densitometry compared with the reference point set to 1 1. Data are representative of 3 impartial experiments. To determine whether FKB induces autophagy through the ER stress-mediated ATF4-DDIT3 pathway, siRNAs were transfected into U251 cells and the protein levels of DDIT3 and MAP1LC3B-II were measured by western blot. Levels of DDIT3 and MAP1LC3B-II did not increase in ATF4-knockdown U251 cells, despite treatment with FKB, to the levels in control-knockdown cells (Physique 5B). U251 cells transfected with siRNA also exhibited poor increases in MAP1LC3B-II protein levels after FKB treatment relative to control-knockdown cells (Physique 5C). Activation of the ER stress signaling was, however, partially restored in knockdown cells when treated simultaneously with an ER stress antagonist, 4-phenylbutyrate (4-PBA, 1?mM; Physique 5D). These results exhibited that FKB induced autophagy through activation of the ATF-DDIT3 ER stress signaling pathway in GBM cells. FKB induces autophagy through the ATF4-DDIT3-TRIB3-AKT-MTOR-RPS6KB1 signaling pathway in.
